Vellucci S V, Webster R A
Psychopharmacology (Berl). 1982;78(3):256-60. doi: 10.1007/BF00428161.
The antagonism of the anticonflict effect of chlordiazepoxide (CDP) by beta-carboline carboxylic acid ethyl ester (BCCE), Ro 15-1788 and ACTH(4--10) has been evaluated in the Geller-Seifter rat conflict test in which CDP increases punished (conflict), but not unpunished responding. BCCE (0.5--10 micrograms ICV) produced a dose-dependent reduction in the anticonflict activity of CDP. This was also significantly reduced by Ro 15-1788 (25 mg/kg IP) and a high dose of ACTH(4--10) (5 micrograms ICV). None of these test compounds had a marked direct effect on punished or unpunished responding in the dose used. These experiments provide further physiological support for the suggestion from binding studies that BCCE and Ro 15-1788 act on benzodiazepine receptors. However, the ability of ACTH(4--10) to reduce the anticonflict effect of CDP may be by some other, possibly opioid, mechanism.
在盖勒 - 西弗特大鼠冲突试验中,已评估了β - 咔啉羧酸乙酯(BCCE)、Ro 15 - 1788和促肾上腺皮质激素(4 - 10)(ACTH(4--10))对氯氮卓(CDP)抗冲突作用的拮抗作用。在该试验中,CDP增加受惩罚(冲突)反应,但不增加未受惩罚反应。BCCE(脑室内注射0.5 - 10微克)使CDP的抗冲突活性呈剂量依赖性降低。Ro 15 - 1788(腹腔注射25毫克/千克)和高剂量的ACTH(4--10)(脑室内注射5微克)也使其显著降低。在所使用的剂量下,这些受试化合物对受惩罚或未受惩罚反应均无明显直接作用。这些实验为结合研究中关于BCCE和Ro 15 - 1788作用于苯二氮䓬受体的建议提供了进一步的生理学支持。然而,ACTH(4--10)降低CDP抗冲突作用的能力可能是通过其他一些机制,可能是阿片类机制。